Eton Pharmaceuticals, Inc. - Common Stock (ETON)

CUSIP: 29772L108

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+1,276,640
Put/Call ratio
0.19%
SEC-reported price per share
$6.00
Number of holders
47
Value change
+$8,311,784
Number of buys
23
Open additional details 1 more signal available
Number of sells
16
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,281,304

Security key

29772L108

Report period

Q3 2024

Institutions

47

Top holders

10

Ownership snapshot

Top reported holders of ETON - Eton Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $7,879,550 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Opaleye Management Inc. has the largest disclosed position value at $7.88M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Opaleye Management Inc.'s linked filing trail.
Disclosed position value Top 5
Opaleye Management Inc. $7.88M
VANGUARD GROUP INC $3.38M
Nantahala Capital Management, LLC $3.1M
Westside Investment Management, Inc. $1.93M
Acuitas Investments, LLC $1.91M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Opaleye Management Inc.
13F
Company
13F
—
denominator unverified
$7,879,550
2,395,000 shares
— 30 Jun 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$3,381,093
1,027,688 shares
— 30 Jun 2024
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$3,095,012
940,733 shares
— 30 Jun 2024
Westside Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$1,925,973
585,400 shares
— 30 Jun 2024
Acuitas Investments, LLC
13F
Company
13F
—
denominator unverified
$1,908,068
579,960 shares
— 30 Jun 2024
National Philanthropic Trust
13F
Company
13F
—
denominator unverified
$1,619,048
492,112 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
47
Shares
9,507,414
Rows available
47
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
44
Q3 2024 holders
47
Holder diff
3
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .